Keywords

• Hemin
• API Hemin Powder
• Hemin 99%

Quick Details

• ProName: Best price to buy API raw material Ant...
• CasNo: 16009-13-5
• Molecular Formula: C34H32ClFeN4O4
• Appearance: Black fine powder
• Application: Supplement Fe products
• DeliveryTime: 3-5 working days to shipping
• PackAge: aluminized paper
• Port: Shanghai, Guangzhou, HongKong
• ProductionCapacity: 1000 Metric Ton/Month
• Purity: 99% MIN
• Storage: Cold Dry avoid light storage
• Transportation: Sea, Air, Express
• LimitNum: 2 Kilogram
• Related Substances: ≥99% HPLC
• Residue on Ignition: ≥1.0%
• Heavy Metal: ≤10.0 ppm
• Valid Period: 2 Years
• Raw material: Compound
• Application: Supplement, improve body Fe
• Grade: Medicine Grade, food grade
• Appearance: Dark Black fine Powder
• CAS: 16009-13-5
• M.F.: C34H32ClFeN4O4
• M.W.: 651.94
• Specification: 99%

Superiority

Building Healthy Life

Professional Factory 
We has a complete production and operating system, with an annual output capacity of 2000 tons. It can produce variety of content and proportion of extract according to the demand.

Details

Best price to buy API raw material Anti-anemic highest purity Hemin Powder 99%

   Hemin (haemin; ferric chloride heme) is an iron-containing porphyrin with chlorine that can be formed from a haem group.

1. Hemin is protoporphyrin IX containing a ferric iron (Fe3+) ion with a coordinating chloride ligand;
 

2. Chemically, hemin differs from the related heme-compound hematin chiefly in that the coordinating ion is a chloride ion in hemin, whereas the coordinating ion is an hydroxide ion in hematin.The iron ion in haem is ferrous (Fe2+), whereas it is ferric (Fe3+) in both hemin and hematin;
 

3. Hemin is endogenously produced in the human body, for example during the turnover of old red blood cells. It can form inappropriately as a result of hemolysis or vascular injury.
 

4. A lyophilised form of hemin is used as a pharmacological agent in certain cases for the treatment of porphyria attacks, particularly in acute intermittent porphyria. Administration of hemin can reduce haem deficits in such patients, thereby suppressing the activity of delta-amino-levulinic acid synthase (a key enzyme in the synthesis of the porphyrins) by biochemical feedback, which in turn reduces the production of porphyrins and of the toxic precursors of haem. In such pharmacological contexts, hemin is typically formulated with human albumin prior to administration by a medical professional, to reduce the risk of phlebitis and to stabilise the compound, which is potentially reactive if allowed to circulate in free-form.

1. Applied to Nutritional supplements products;
 

2. Applied to Food additives;
 

3. Applied to Pharma product for anti-tumor and anti-anemic;
 

4. Applied to cosmetics products.